ImmuneSensor Therapeutics ImmuneSensor Therapeutics is a company aiming to treat cancer and autoimmune diseases. | ![]() CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | ![]() Carrick Therapeutics Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments. | ![]() NMS Group NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs. | |
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2015 | Founding Date N/A |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Dallas, US HQ | Locations South San Francisco, US HQ | Locations Dublin, IE HQ Oxford, GB | Locations Nerviano, IT HQ |
Employees | Employees 11 | Employees 15815% increase | Employees 17 | Employees 76 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 132.4m | Total funding raised $ 95m | Total funding raised N/A |

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments.
View company
NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs.
View company